Display options
Cite
Matysiak J, Juszczak M, Karpińska MM, et al. Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents. Monatsh Chem. 2015;146(8):1315-1327doi: 10.1007/s00706-015-1453-4.
Matysiak, J., Juszczak, M., Karpińska, M. M., Langner, E., Walczak, K., Lemieszek, M., Skrzypek, A., Rzeski, W., & Niewiadomy, A. (2015). Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents. Monatshefte fur chemie, 146(8), 1315-1327. https://doi.org/10.1007/s00706-015-1453-4
Matysiak, Joanna, et al. "Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents." Monatshefte fur chemie vol. 146,8 (2015): 1315-1327. doi: https://doi.org/10.1007/s00706-015-1453-4
Matysiak J, Juszczak M, Karpińska MM, Langner E, Walczak K, Lemieszek M, Skrzypek A, Rzeski W, Niewiadomy A. Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents. Monatsh Chem. 2015;146(8):1315-1327. doi: 10.1007/s00706-015-1453-4. Epub 2015 Apr 02. PMID: 26190864; PMCID: PMC4498246.
Copy Download .nbib Format: NLM
Share it on

Monatsh Chem. 2015;146(8):1315-1327. doi: 10.1007/s00706-015-1453-4. Epub 2015 Apr 02.

Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents.

Monatshefte fur chemie

Joanna Matysiak, Małgorzata Juszczak, Monika M Karpińska, Ewa Langner, Katarzyna Walczak, Marta Lemieszek, Alicja Skrzypek, Wojciech Rzeski, Andrzej Niewiadomy

Affiliations

  1. Department of Chemistry, University of Life Sciences in Lublin, Akademicka 15, 20-950 Lublin, Poland.
  2. Department of Medical Biology, Institute of Rural Health in Lublin, Jaczewskiego 2, 20-090 Lublin, Poland.
  3. Institute of Industrial Organic Chemistry in Warsaw, Annopol 6, 03-236 Warsaw, Poland.
  4. Department of Medical Biology, Institute of Rural Health in Lublin, Jaczewskiego 2, 20-090 Lublin, Poland ; Department of Pharmacology, Medical University in Lublin, Chod?ki 4a, 20-093 Lublin, Poland.
  5. Department of Pharmacology, Medical University in Lublin, Chod?ki 4a, 20-093 Lublin, Poland.
  6. Department of Medical Biology, Institute of Rural Health in Lublin, Jaczewskiego 2, 20-090 Lublin, Poland ; Department of Virology and Immunology, Maria Curie-Sk?odowska University in Lublin, Akademicka 19, 20-033 Lublin, Poland.
  7. Department of Chemistry, University of Life Sciences in Lublin, Akademicka 15, 20-950 Lublin, Poland ; Institute of Industrial Organic Chemistry in Warsaw, Annopol 6, 03-236 Warsaw, Poland.

PMID: 26190864 PMCID: PMC4498246 DOI: 10.1007/s00706-015-1453-4

[No abstract available.]

Keywords: ADMET; Antiproliferative activity; Azolothiazinones; Cytotoxicity; Resorcinols

References

  1. J Org Chem. 2013 Jun 7;78(11):5117-41 - PubMed
  2. Chem Res Toxicol. 2008 Jan;21(1):70-83 - PubMed
  3. J Agric Food Chem. 2002 Aug 14;50(17):4839-45 - PubMed
  4. J Pharm Sci. 2001 Apr;90(4):436-47 - PubMed
  5. Mol Cancer Ther. 2006 Jun;5(6):1628-37 - PubMed
  6. Clin Cancer Res. 2013 Jul 1;19(13):3671-80 - PubMed
  7. J Mol Graph Model. 2013 Sep;45:202-10 - PubMed
  8. Bioorg Med Chem Lett. 2005 Jul 15;15(14):3338-43 - PubMed
  9. Mol Cancer Ther. 2007 Apr;6(4):1198-211 - PubMed
  10. Cancer Res. 2008 Apr 15;68(8):2850-60 - PubMed
  11. Curr Top Med Chem. 2006;6(11):1193-203 - PubMed
  12. Chem Biodivers. 2012 Jan;9(1):48-57 - PubMed
  13. Acta Pharmacol Sin. 2005 Apr;26(4):500-12 - PubMed
  14. J Med Chem. 2008 Feb 14;51(3):373-5 - PubMed
  15. Bioorg Med Chem. 2006 Sep 1;14(17):6106-19 - PubMed
  16. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1089-92 - PubMed
  17. J Mol Graph Model. 2000 Aug-Oct;18(4-5):512-24, 541 - PubMed
  18. Bioorg Med Chem. 2012 Feb 1;20(3):1181-7 - PubMed
  19. Bioorg Med Chem Lett. 2000 Jun 5;10(11):1155-8 - PubMed
  20. Mol Cancer Ther. 2009 Apr;8(4):921-9 - PubMed
  21. Eur J Med Chem. 2010 Jun;45(6):2336-44 - PubMed
  22. Leukemia. 2010 Oct;24(10):1804-7 - PubMed
  23. Curr Pharm Des. 2009;15(19):2184-94 - PubMed
  24. Chem Biol Drug Des. 2009 Jul;74(1):43-50 - PubMed
  25. Cancer Res. 2007 Mar 1;67(5):2206-16 - PubMed
  26. Clin Cancer Res. 2014 Aug 1;20(15):3945-54 - PubMed
  27. Breast Cancer Res. 2008;10(2):R33 - PubMed
  28. Leukemia. 2008 Aug;22(8):1604-12 - PubMed
  29. J Pharmacol Exp Ther. 1949 Jun;96(2):99-113 - PubMed
  30. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5197-201 - PubMed
  31. J Med Chem. 2008 Jan 24;51(2):196-218 - PubMed
  32. Arch Pharm (Weinheim). 2011 Apr;344(4):224-30 - PubMed
  33. Curr Drug Metab. 2008 Nov;9(9):845-6 - PubMed
  34. Org Lett. 2004 Nov 25;6(24):4459-62 - PubMed
  35. J Pharm Sci. 1999 Jan;88(1):28-33 - PubMed
  36. J Med Chem. 2014 Mar 27;57(6):2258-74 - PubMed
  37. Eur J Med Chem. 2002 Mar;37(3):255-60 - PubMed

Publication Types